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Abstract

Enhanced long-lasting AFC response in Mer-/- mice

Mer (MerTK), a member of the Tyro-3/Axl/Mer subfamily receptor
tyrosine kinases, expression on phagocytes facilitates their clearance of
apoptotic cells (ACs). Mer expression in germinal centers (GCs) occurs
predominantly on tingible body macrophages (TBMs). B and T cells do
not express Mer. Mer deficiency (Mer-/-) results in the accumulation of
ACs in GCs and augmented antibody-forming cell (AFC), GC and IgG2
Ab responses against T-dependent (TD) Ag. Here, we show that AC
accumulation in GCs and elevated AFC, GC and IgG2 Ab responses in
Mer-/- mice lasted for at least 80 days after immunization with NP-OVA.
Enhanced responses and AC accumulation in Mer-/- GCs were
associated with increased activation and proliferation of B cells and
activated effector helper T cells, including follicular T (TFH) cells.
Secondary IgG-producing AFC, total IgG and IgG2 Ab responses were
also increased in Mer-/- mice. Augmented B and T cell responses and
long-term AC accumulation in Mer-/- GCs were linked to high titers of
anti-nuclear antibodies (ANAs) in Mer-/- mice compared to wild type
(WT) controls. Together, these results highlight the important role of AC
clearance by Mer in regulating GC B cell, helper T cell and autoantibody
responses and in maintaining peripheral B cell tolerance.

Figure 3. The number of shortlived splenic NP-specific IgM (A
and C) and IgG (B and D)
secreting AFCs were measured
by ELISpot assay 14 and 21
days after immunization of WT
(open circle) and Mer-/- (closed
circle) mice with NP-OVA. The
number of long-lived splenic (E)
and bone marrow-derived (F)
NP-specific IgG-producing
AFCs were measured 80 days
post-immunization. Each circle
represents the number of AFCs
per 1x106 splenocytes obtained
from an individual mouse.
Horizontal bars represent the
average values. These data
were obtained from age- and
sex-matched four to seven mice
of each genotype. Statistical
analysis was performed by
Student’s t-test.

Augmented IgG and Th1-IgG2 Ab responses in Mer-/- mice
over time

Methods and Results
Long-term accumulation of ACs in Mer-/- GCs
Figure 1. Three-color
immunohistology of
spleen tissue obtained
on day 14 (A), 21 (B)
and 80 (C) post-NPOVA immunization of
WT and Mer-/- mice.
Spleen sections were
stained with GL7,
TUNEL and antiCD68. GCs are
defined by the
presence of GL7+
cells. Two- (TUNEL
and anti-CD68) and
three-color (GL7,
TUNEL and antiCD68) overlay images
are shown in the 3rd
and 4th columns,
respectively. Original
magnification of
images was 200x.
These data represent
age- and sex-matched
seven to eight mice of
each genotype for
each time point.

Primary GC response in the presence and absence of Mer

Figure 2. Flow cytometric analysis of splenocytes obtained from WT and Mer-/- mice on days
14 (A), 21 (B) and 80 (C) post-immunization with NP-OVA. Cells were stained with GC B cell
markers (B220, PNA and anti-CD95/Fas). B220+PNAhiFashi GC B cells are shown in rectangular
gates (A and B, left panels) and the percentage of B220+PNAhiFashi GC B cells in WT (open
circle) and Mer-/- (closed circle) mice is shown in scatter plots (A and B, right panels). Analysis
on day 80 was performed on pooled samples of seven WT control (top) and four Mer-/- (bottom)
mice where B220+PNAhiFashi GC B cells are shown in rectangular gates (C). Spleen sections
obtained from WT (D and F) and Mer-/- mice (E and G) on days 21 and 80 were stained with
anti-IgD and PNA. Low (50x) and high magnification (200x) representative images are shown.

Elevated CD4+ helper T cell responses in Mer-/- mice

Figure 6. The percentage of CD4+CD44hiCD62Llo (middle panels) and CD4+CD44hiCD62Lhi (right
panels) T cells in WT and Mer-/- mice is shown in (A) and (B). (C, D): The percentage of CD4+CD25+
T cells in WT and Mer-/- mice. (E, F): The percentage of CD4+CXCR5hiPD-1hi TFH cells in WT and
Mer-/- mice is shown in right panels (E, F). Statistical analysis was performed by Student’s t-test.
These data were obtained from sex and age-matched seven mice of each genotype.

Long-term accumulation of ACs in Mer-/- GCs associated
with high titers of ANAs

Figure 7. Anti-dsDNA (A), anti-histone (B) and anti-nucleosome (C) Abs were measured by ELISA
in serum samples obtained from a group of WT (open circle, n =12) and Mer-/- (closed circle, n = 9)
mice on multiple time points before (d0) and after (d28, d60 and d80) immunization with NP-OVA.
The dashed lines represent WT and solid lines represent Mer-/- mice. Each circle represents one
individual mouse and bars represent the mean values. Statistical analysis was performed by
Student’s t-test. P values of <0.05 and <0.01 are depicted as * and **, respectively.
Figure 4. Anti-NP IgM (A), IgG (B), IgG1 (C) and IgG2 (D) Ab titers were measured by ELISA in
WT (open circle) and Mer-/- (closed circle) serum samples obtained on multiple time points (days
14, 21, 28, 45, 60 and 80) post-immunization of these mice with NP-OVA. The dashed lines
represent WT and solid lines represent Mer-/- mice. Each circle represents an individual mouse
and horizontal bars represent the mean values. Statistical analysis was performed by the Student’s
t-test. P values of <0.05 and <0.01 are depicted as * and **, respectively. These data were obtained
from age- and sex-matched five to six mice of each genotype at each time point.

Augmented secondary AFC and IgG2 Ab responses
in Mer-/- mice

Significantly increased percentages of activated and
proliferating B cells in Mer-/- GCs
Figure 5. B cell
activation was
evaluated by
flow cytometric
analysis of
spleen cells
obtained on
days 14 (A)
and 21 (B)
postimmunization of
WT and Mer-/mice with NPOVA. Spleen
cells were
stained with
antibodies
against B cell
activation
markers CD80
(A and B, left
two panels)
and CD86 (A
and B, right two
panels). The
percentage of
B220+CD80+ (left panels) and B220+CD86+ (right panels) cells in WT and Mer-/- mice is shown in
scatter plots. (C): Immunohistological analysis was performed on two consecutive spleen sections
obtained from WT (top row) and Mer-/- (bottom row) mice on day 21 after NP-OVA immunization:
one stained using anti-IgD and PNA and the other with anti-IgD and anti-BrdU. (D): Semiquantitative analysis of the number of BrdU+ proliferating B cells per GC was performed by
counting BrdU+ cells in 45-50 representative GCs from seven WT and eight Mer-/- mice.

Figure 8. IgG-producing secondary AFCs in the spleen was measured by ELISpot assay four days
after boosting WT and Mer-/- mice with NP-OVA. The anti-NP IgG (B), IgG1 (C) and IgG2 (D) Abs
were measured by ELISA in serum samples collected from mice described in (A). Age- and sexmatched five to six mice of each genotype were used to generate these data.

Conclusion
 Long-term accumulation of ACs in GCs in the absence of Mer
associated with enhanced primary GC and AFC responses
 Elevated total IgG and Th1-IgG2 Ab responses in Mer-/- mice
 Significantly increased percentages of activated B and helper T cells,
including TFH cells, and proliferating GC B cells in the absence of Mer
 Long-term AC accumulation in Mer-/- GCs associated with
high titers of ANAs
Augmented secondary AFC and IgG2 Ab responses in Mer-/- mice
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